Biomarkers to Predict DMARDs Efficacy and Adverse Effect in Rheumatoid Arthritis
Rheumatoid arthritis (RA), one of the most common immune system diseases, mainly affects middle-aged and elderly individuals and has a serious impact on the quality of life of patients. Pain and disability caused by RA are significant symptoms negatively affecting patients, and they are especially s...
Main Authors: | Kai Wei, Ping Jiang, Jianan Zhao, Yehua Jin, Runrun Zhang, Cen Chang, Lingxia Xu, Linshuai Xu, Yiming Shi, Shicheng Guo, Dongyi He |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.865267/full |
Similar Items
-
Metabolomics in rheumatoid arthritis: Advances and review
by: Lingxia Xu, et al.
Published: (2022-08-01) -
MicroRNA-Mediated Epigenetic Regulation of Rheumatoid Arthritis Susceptibility and Pathogenesis
by: Cen Chang, et al.
Published: (2022-03-01) -
SFRP1 Negatively Modulates Pyroptosis of Fibroblast‐Like Synoviocytes in Rheumatoid Arthritis: A Review
by: Ping Jiang, et al.
Published: (2022-06-01) -
G-Protein-Coupled Receptors in Rheumatoid Arthritis: Recent Insights into Mechanisms and Functional Roles
by: Jianan Zhao, et al.
Published: (2022-07-01) -
Inflammatory Response to Regulated Cell Death in Gout and Its Functional Implications
by: Jianan Zhao, et al.
Published: (2022-04-01)